SE OF KAILAS JEEVAN FOR PILES & FISSURES
Phase 1
Completed
- Conditions
- Health Condition 1: K641- Second degree hemorrhoids
- Registration Number
- CTRI/2019/07/020311
- Lead Sponsor
- Ayurved Sumshodhanalaya Pune Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
PREGNANT LADIES ALSO INCLUDED
Exclusion Criteria
1. THIRD & FOURTH DEGREE PILES
2. FISTULA, ISCHIORECTAL ABSCESS, MALIGNANCY
& HIV POSITIVE
3. LIVER CIRRHOSIS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Local Symptoms of Arsha ( Haemorrhoids) & Parikartika (Ano - rectal Fissure)Timepoint: Reduction in symptoms will be assessed after 3 weeks & a follow up after 5 weeks to assess recurrence if any
- Secondary Outcome Measures
Name Time Method Reduction in Local Symptoms of Arsha ( Haemorrhoids) & Parikartika (Ano - rectal Fissure)Timepoint: 5 Weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the active compounds and molecular mechanisms of Kailas Jeevan in treating second-degree hemorrhoids and anal fissures?
How does Kailas Jeevan's efficacy in pregnant patients compare to standard-of-care treatments like rubber band ligation or topical corticosteroids?
Are there specific biomarkers or patient characteristics that predict response to Kailas Jeevan in anorectal fissures and hemorrhoids during pregnancy?
What adverse events were observed in the phase I trial of Kailas Jeevan for hemorrhoids and anal fissures, particularly in pregnant subjects?
What are the potential synergies between Kailas Jeevan and conventional therapies like calcium channel blockers for anal fissures?